-
Uncategorized2 months ago
Insmed shelves Brinsupri in skin disease after mid-stage flop
Insmed has given up on Brinsupri in the painful skin disorder hidradenitis suppurativa (HS) after a mid-stage trial failure. The company had ditched the pill in...
-
Uncategorized2 months ago
New Single‑Cell Platform Tracks RNA and Protein in Immune Signaling
A new single‑cell sequencing method is giving researchers a clearer view of how immune cells actually behave—capturing not just what they plan to do, but what...
-
Uncategorized2 months agoSTAT+: A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope
A year after the worst day of her life, Debra Miller received a voicemail she couldn’t quite make out. In a thick accent, a man said...
-
Uncategorized2 months agoOpinion: What American hospitals can learn from India about waste
The first time we stepped into an operating theater in the United States as medical students, we were shocked by the sheer amount of waste produced...
-
Uncategorized2 months ago
European VC Jeito gets $1.2B to help private biotechs control their ‘destiny’
European VC Jeito gets $1.2B to help private biotechs control their 'destiny'
-
Uncategorized2 months ago
Scientists just uncovered the secret behind nature’s “proton highway”
Scientists have zoomed in on how phosphoric acid moves electrical charges so efficiently in both biology and technology. By freezing a key molecular pair to extremely...
-
Uncategorized2 months ago
Activation mechanism and integrated one-pot assay of chiral-like cRNA-enhanced CRISPR/Cas12a systems
Post Content
-
Uncategorized2 months ago
Sequence Display enables large-scale sequence–activity datasets for rapid protein evolution
Nature Biotechnology, Published online: 08 April 2026; doi:10.1038/s41587-026-03087-3 Sequence Display maps protein variant activities to a sequencing-based readout.
-
Uncategorized2 months agoJudge refuses to block sending abortion pill by mail for now, but says FDA must finish review
A federal judge Tuesday refused to block filling prescriptions for the abortion pill mifepristone by mail across the U.S. — at least for now — in...
-
Uncategorized2 months ago
Neurocrine Grows in Endocrinology, Rare Disease with $2.9B Soleno Buyout
Neurocrine Biosciences has agreed to acquire Soleno Therapeutics for $2.9 billion, the companies said, in a deal designed to bolster the buyer’s portfolio of marketed endocrinology...
Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
